Literature DB >> 28415380

miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers.

Haiyu Zhou1, Zhizhou Huang2, Xuemei Chen3, Size Chen4.   

Abstract

Evidence is mounting that micro RNAs (miRNAs) play a critical role in tumor development. However, the role of miRNAs in lung cancer progression remains largely unknown. Herein, we found that miR-98 significantly impaired in patients with non-small cell lung cancers (NSCLC) and was a novel regulator of NSCLC progression. Patients with high miR-98 expression had a longer overall survival than with low miR-98 expression (p=0.0495). miR-98 expression level inversely correlated with TWIST mRNA level in 71 clinical tissue specimens of NSCLC (p<0.01). Luciferase assay demonstrated that miR-98 interacted binding sites in the TWIST 3'-UTR and reduced expression of TWIST, resulting in repression of cell migration and invasion via impeding TWIST-mediated EMT. Furthermore, introduction of synthetic miR-98 caused growth arrest by inactivating TWIST-Akt-CDK4/CDK6. Meanwhile, miR-98 mimic induced apoptosis by targeting TWIST-Akt axis. In a conclusion, these observations imply that miR-98 may act as a tumor suppressor in NSCLC to decelerate NSCLC aggressiveness by inhibiting TWIST expression.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Invasiveness; NSCLC; Proliferation; TWIST; miR-98

Mesh:

Substances:

Year:  2017        PMID: 28415380     DOI: 10.1016/j.biopha.2017.01.012

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

Review 1.  The Role of MicroRNA in the Regulation of Tumor Epithelial-Mesenchymal Transition.

Authors:  Jing Feng; Shaofan Hu; Keli Liu; Guiyin Sun; Yiguo Zhang
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 2.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

3.  A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.

Authors:  Farhana Matin; Varinder Jeet; Leire Moya; Luke A Selth; Suzanne Chambers; Judith A Clements; Jyotsna Batra
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

4.  Mechanism of miR-98 inhibiting tumor proliferation and invasion by targeting IGF1R in diabetic patients combined with colon cancer.

Authors:  Shixiong Liu; Yun Zhou; Yongning Zhou; Jing Wang; Rui Ji
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

5.  Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.

Authors:  Yue Fu; Xinchun Liu; Qiuyang Chen; Tongtai Liu; Cheng Lu; Jun Yu; Yi Miao; Jishu Wei
Journal:  J Exp Clin Cancer Res       Date:  2018-07-03

Review 6.  Functional Role of Non-Coding RNAs during Epithelial-To-Mesenchymal Transition.

Authors:  Almudena Expósito-Villén; Amelia E Aránega; Diego Franco
Journal:  Noncoding RNA       Date:  2018-05-28

7.  Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98.

Authors:  Zhuangzhuang Cong; Yifei Diao; Yang Xu; Xiaokun Li; Zhisheng Jiang; Chenye Shao; Saiguang Ji; Yi Shen; Wei De; Yong Qiang
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

Review 8.  Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer.

Authors:  Young-Ho Ahn; Yoon Ho Ko
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

9.  MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1.

Authors:  Feng Jiang; Qiuhua Yu; Ying Chu; Xiaobo Zhu; Wenbin Lu; Qian Liu; Qiang Wang
Journal:  Int J Oncol       Date:  2018-10-29       Impact factor: 5.650

10.  miR-98-5p Alleviated Epithelial-to-Mesenchymal Transition and Renal Fibrosis via Targeting Hmga2 in Diabetic Nephropathy.

Authors:  Yingchun Zhu; Jiang Xu; Wenxing Liang; Ji Li; Linhong Feng; PengXi Zheng; Tingting Ji; Shoujun Bai
Journal:  Int J Endocrinol       Date:  2019-11-26       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.